These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2800618)

  • 21. Treatment outcomes and relapses of pulmonary tuberculosis in Lazio, Italy, 1999-2001: a six-year follow-up study.
    Faustini A; Hall AJ; Mantovani J; Sangalli M; Perucci CA;
    Int J Infect Dis; 2008 Nov; 12(6):611-21. PubMed ID: 18395482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Which patients are dying of tuberculosis in the 90-s?].
    Vadász I; Popovics Z; Fodor T
    Orv Hetil; 1993 Oct; 134(42):2305-7. PubMed ID: 8233445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis.
    Weiner M; Benator D; Burman W; Peloquin CA; Khan A; Vernon A; Jones B; Silva-Trigo C; Zhao Z; Hodge T;
    Clin Infect Dis; 2005 May; 40(10):1481-91. PubMed ID: 15844071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recurrences, epidemiometric indicator and results of tuberculosis prevention].
    Mihăilescu P; Plopeanu D
    Ftiziologia; 1973; 22(3):237-50. PubMed ID: 4576113
    [No Abstract]   [Full Text] [Related]  

  • 26. Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City.
    Driver CR; Munsiff SS; Li J; Kundamal N; Osahan SS
    Clin Infect Dis; 2001 Nov; 33(10):1762-9. PubMed ID: 11595988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relapse rate of pulmonary tuberculosis within two years following completion of twice weekly intermittent chemotherapy].
    Wada M; Okumura M; Hoshino H; Mitarai S; Ohmori M; Uchimura K; Yoshiyama T; Ogata H
    Kekkaku; 2008 Apr; 83(4):353-8. PubMed ID: 18516898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of treatment and immunological recovery on tuberculosis relapses in HIV-infected patients.
    Lopez-Cortes LF; Marin-Niebla A; Lopez-Cortes LE; Villanego I; Rodriguez-Diez M; Pascual-Carrasco R
    Int J Tuberc Lung Dis; 2005 Dec; 9(12):1385-90. PubMed ID: 16466062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
    Berkani M; Chaulet P; Darbyshire JH; Nunn A; Fox W
    Rev Mal Respir; 1986; 3(2):73-85. PubMed ID: 3726263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Risk factors and their significance in the development of diffuse forms of tuberculosis in adolescents].
    Firsova VA; Ovsiankina ES; Iatskova TV
    Probl Tuberk; 1995; (6):12-5. PubMed ID: 8524758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Time trend in incidence and mortality of tuberculosis and characteristics of notified tuberculosis patients in urban area of Mongolia].
    Toyota M
    Kekkaku; 1998 Jul; 73(7):477-83. PubMed ID: 9739580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Risk factors for the development of early relapse in pulmonary tuberculosis after chemotherapy].
    Eĭsaev BA
    Ter Arkh; 1987; 59(7):85-7. PubMed ID: 3672367
    [No Abstract]   [Full Text] [Related]  

  • 33. [The development of tuberculosis epidemiology in the German Democratic Republic].
    Steinbrück P; Herrmann H
    Z Erkr Atmungsorgane; 1982; 158(1-2):81-94. PubMed ID: 7072275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Women and tuberculosis.
    Connolly M; Nunn P
    World Health Stat Q; 1996; 49(2):115-9. PubMed ID: 9050189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A refined symptom-based approach to diagnose pulmonary tuberculosis in children.
    Marais BJ; Gie RP; Hesseling AC; Schaaf HS; Lombard C; Enarson DA; Beyers N
    Pediatrics; 2006 Nov; 118(5):e1350-9. PubMed ID: 17079536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-resistant tuberculosis in Taipei, 1996-1999.
    Wang PD; Lin RS
    Am J Infect Control; 2001 Feb; 29(1):41-7. PubMed ID: 11172317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A study on the relapse and its potential causes in pulmonary tuberculosis].
    Liu XR
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):69-72, 122. PubMed ID: 8221953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resectional surgery combined with chemotherapy remains the treatment of choice for multidrug-resistant tuberculosis.
    Shiraishi Y; Nakajima Y; Katsuragi N; Kurai M; Takahashi N
    J Thorac Cardiovasc Surg; 2004 Oct; 128(4):523-8. PubMed ID: 15457152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
    Shigetoh E; Murakami I; Yokosaki Y; Kurimoto N
    Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.